Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates

Century Therapeutics, Inc. (IPSC) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of$ 0.50. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10%. A quarter ago, it was expected that this company would post a loss of$ 0.56 per share when it actually produced a loss of $0.49, delivering a surprise of 12.50%.Over the last four quarters, the company has ...